Richard Chesworth
Keine laufenden Positionen mehr
Profil
Richard Chesworth worked as Senior Vice President-Research at Epizyme, Inc. and as Chief Scientific Officer at Kymera Therapeutics, Inc. He holds a doctorate degree from the University of Oxford and an undergraduate degree from Imperial College London.
Ehemalige bekannte Positionen von Richard Chesworth
Unternehmen | Position | Ende |
---|---|---|
KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 22.10.2021 |
EPIZYME, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Richard Chesworth
University of Oxford | Doctorate Degree |
Imperial College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KYMERA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |